Open main menu
Blog HomeProductContact

Case Study

How HealthKey found 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial.
OncologyDevice
•

How HealthKey found 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial.

US Urology Partners had one month before a J&J bladder cancer trial closed enrollment. HealthKey screened 431 patients and 353,000 medical records, found 16 with intermediate-risk NMIBC, and identified 2 eligible patients with 6 more staged for recurrence.

How HealthKey Screened Two Clinics in Parallel for a Phase 2 Bladder Cancer Trial.
OncologyUrology
•

How HealthKey Screened Two Clinics in Parallel for a Phase 2 Bladder Cancer Trial.

US Urology Partners' care navigation team couldn't scale to every location. HealthKey screened 1,452 patients and 859,000 medical records across two clinics simultaneously, finding eligible patients at each site and enrolling both for CG Oncology's CORE-008 trial.

"Will Not Be an Easy Protocol." How Tekton Went From a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.
Rheumatology
•

"Will Not Be an Easy Protocol." How Tekton Went From a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.

UCB's bimekizumab protocol had 42 eligibility criteria across two disease cohorts. Tekton Research used HealthKey to screen 650 patients and surface 14 qualified candidates in 11 days, 2.8x the enrollment target, for a trial the site couldn't have staffed manually.

"I Was Doing This by Hand for a Year." How Tekton Research Cut RA Trial Chart Review by 97%.
Rheumatology
•

"I Was Doing This by Hand for a Year." How Tekton Research Cut RA Trial Chart Review by 97%.

Tekton’s Site Manager was manually screening 1,300 rheumatoid arthritis patient charts for a Merck Phase 2b trial. HealthKey processed 2,087 patients and 1.7 million medical records, narrowing her review to 40 charts and saving 626 hours.

How Oregon Urology Institute Found 6 PSMA-DC Patients in 1 Week (After Enrolling Zero for Two Years)
Oncology
•

How Oregon Urology Institute Found 6 PSMA-DC Patients in 1 Week (After Enrolling Zero for Two Years)

Oregon Urology Institute searched for eligible clinical trial patients for the Novartis PSMA-DC study for two years with zero enrollments. HealthKey processed 5.2 million medical records, identified 6 eligible patients, 3 consented, and 1 enrolled.

How Urology Centers of Alabama Screened 22,701 Patients and Found 68 Eligible for the eCoin Trial
UrologyDevice
•

How Urology Centers of Alabama Screened 22,701 Patients and Found 68 Eligible for the eCoin Trial

Urology Centers of Alabama struggled with manual chart review for the Valencia eCoin trial. HealthKey processed 2.4 million medical records, identified 68 eligible patients across 20 criteria, and enrolled 3 new patients within weeks.